Discovery May Lead to Improvements in Treating Alzheimer's Disease
the Psychiatry Advisor take:
A new drug target to fight Alzheimer's disease might also be used as a diagnostic tool for the disease, according to researchers at Pennsylvania State University.
A team found that the GABA neurotransmitter was drastically increased in the deformed versions of the normally large, star-shaped "astrocyte" cells which,support individual neurons in the brain. High concentrations of that neurotransmitter is a novel biomarker that researchers hope can be further investigated a a diagnosis tool and for treatment.
Research behind many drugs in development for Alzheimer's targets the sticky buildup of the amyloid protein known as plaques, which can cause neurons in the brain to die.
Japanese Drugmaker Accelerates Development of Alzheimer's Drug
Psychiatry Advisor Articles
- Early Detection Markers of Alzheimer's Disease Possibly Identified
- Transcranial Direct Current Stimulation Inferior to Escitalopram
- Illicit Cannabis Use Among Adults Up Due to Medical Marijuana Laws
- Memory Training Opportunities Exist for Patients With Schizophrenia
- APA: Medical Discrimination Based on Size Psychologically, Physically Harms Patients
- Criteria For Identification of Smartphone Addiction
- Bipolar Disorder: Childhood Trauma Modulates Impact on Amygdala, Hippocampus
- Psychiatric Evaluations: Questions on Suicide Need to Be Rephrased
- Subsequent Suicide Attempts May Be Reduced by Emergency Department Interventions
- Elevated Levels of Childhood Adversity in Patients with Fibromyalgia and Chronic Widespread Pain
- Prescription Opioid Misuse Remains a Persistent Problem
- Revised Treatment Guidelines for Pediatric Acute Onset Neuropsychiatric Syndrome
- Long-term Response to Prophylactic Mood Stabilizers in Bipolar Disorder
- Medically Supervised Withdrawal, an Option for Pregnant Women Addicted to Opioids
- Navigating the Thin Line Between Identification & Intimacy With Patients